4th Feb 2015 10:48
LONDON (Alliance News) - GlaxoSmithKline PLC has appointed banks as financial advisers on its HIV medicines joint venture ViiV Healthcare, Sky News reported Wednesday.
Sky News reported that it has learnt that Glaxo has hired Citi, Goldman Sachs and Morgan Stanley as financial advisers on the unit. It says the appointment of the banks will fuel the prospect of Glaxo floating the division, which analysts believe could be worth at least GBP17 billion.
Glaxo owns 78% of the joint venture, with the remainder held by Pfizer Inc and Shionogi & Co.
A spokesperson for Glaxo was not immediately available for comment.
http://news.sky.com/story/1421076/gsk-injects-pace-into-blockbuster-hiv-float
Shares in Glaxo are trading up 0.4% at 1,458.96 pence Wednesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline